Peptide and protein PEGylation: a review of problems and solutions

FM Veronese - Biomaterials, 2001 - Elsevier
The paper discusses general problems in using PEG for conjugation to high or low
molecular weight molecules. Methods of binding PEG to different functional groups in …

Chemistry of polyethylene glycol conjugates with biologically active molecules

S Zalipsky - Advanced drug delivery reviews, 1995 - Elsevier
Polyethylene glycol (PEG) is widely used as a covalent modifier of biological
macromolecules and particulates as well as a carrier for low molecular weight drugs. In the …

Functionalized poly (ethylene glycols) for preparation of biologically relevant conjugates

S Zalipsky - Bioconjugate chemistry, 1995 - ACS Publications
One of the best biocompatible polymers, poly (ethylene glycol)(PEG),* 1 possesses an array
of useful properties (1, 2). Among them are a wide range of solubilities in both organic …

PEG− doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity

FM Veronese, O Schiavon, G Pasut… - Bioconjugate …, 2005 - ACS Publications
Polymer− drug conjugates (polymer therapeutics) are finding increasing use as novel
anticancer agents. Here a series of poly (ethylene glycol) PEG− doxorubicin (Dox) …

A branched monomethoxypoly (ethylene glycol) for protein modification

C Monfardini, O Schiavon, P Caliceti… - Bioconjugate …, 1995 - ACS Publications
Procedures are described for linking monomethoxypoly (ethylene glycol)(mPEG) to both e
and a amino groups of lysine. The lysine carboxyl group can then be activated as a …

Protected thiol-polyethylene glycol: a new activated polymer for reversible protein modification

C Woghiren, B Sharma, S Stein - Bioconjugate chemistry, 1993 - ACS Publications
Monomethoxypolyethylene glycol (mPEG) of average molecular weight 5000 was
transformed in a series of synthetic steps to a new activated form of PEG, a stable thiol …

Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity

M Chinol, P Casalini, M Maggiolo, S Canevari… - British journal of …, 1998 - nature.com
Pretargeting techniques using the avidin-biotin system have shown encouraging results in
both diagnostic and therapeutic clinical trials. It has been shown that in cancer therapy the …

Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly (ethylene glycol) and poly (N …

O Schiavon, P Caliceti, P Ferruti, FM Veronese - Il Farmaco, 2000 - Elsevier
Uricase from Bacillus fastidiosus (UC) was covalently linked to linear PEG (PEG-1)(Mw 5
kDa), branched PEG (PEG-2)(Mw 10 kDa) and to poly (N-acryloylmorpholine)(PAcM)(Mw 6 …

Modified FGF-21 polypeptides and their uses

TP Cujec, R Mariani, AMAH PUTNAM… - US Patent …, 2011 - Google Patents
2008-08-19 Assigned to AMBRX, INC. reassignment AMBRX, INC. ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KRAYNOV, VADIM …

Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers

P Caliceti, O Schiavon, FM Veronese - Bioconjugate chemistry, 1999 - ACS Publications
A comparative pharmacokinetic and biodistribution investigation of polymer− protein
conjugates prepared with various amphiphilic polymers was carried out using uricase as a …